Biogen ready with 1st drug to slowdown Alzheimer’s progression

Drug development company Biogen has announced that it will soon seek regulatory approval in USA for the release of its groundbreaking medicine aducanumab.  According to sources it will file the paperwork in early part of 2020 and will soon try to get approval for European markets too. Usually the approval process takes at least a
Read More »